Structural bioinformatics and computer aided design of novel drugs and functional proteins

D.-Q. Wei,L. Li,K.-C. Chou

IF: 3.7891

2007-01-01

Amino Acids

Abstract:Genome projects[1] are yielding protein sequences for which there is no knowledge about function or conformation. The draft human genome has now been available and the exploitation of this unique source of knowledge is a major challenge for biology. In parallel with these sequencing projects, there are structural genomics initiatives involving the determination of the conformations of uncharacterized proteins in the genomes with the particular aim of determining function. In addition, gene expression arrays are providing a mass of data that require analysis to relate protein sequences to activity under different conditions and in different cellular locations. Knowledge of the structure and function of the relevant proteins, revealed by crystallography and NMR, is central to the interpretation and exploitation of this pool of biological information. Three­dimensional structure can guide further experiments to probe activity and direct the systematic design of therapeutic agents for diseases. The experimental determination of protein structure remains difficult. There are large disparities between the numbers of protein sequences. Protein modeling provides a valuable approach to maximize the biological knowledge that can be obtained given these disparities. Accordingly, the task of the Structural Bioinformatics is the development of protein modeling algorithms and the application of the technology to systems of interests. Methodologies based on the known protein structures from experiments have been developed to predict 3D structures from a 1D sequence information, which is known as the homology modeling. It has become a reliable tool as long as the homologue with experimental 3D structure of significant similarity(usually greater than 35%) could be found. Other methods, for example, ab initio molecular dynamics, is still too slow to predict structure of a real protein. Often the structures of many drug targets are not available. The structural bioinformatics tools are needed to generate them readily to initiate drug design processes. We have predicted many protein structures using homology modeling to facilitate the computer aided drug design, which include database screening, pharmacophore search, docking and molecular dynamics conformation search. To join the worldwide efforts[1­7] against H5N1 viruses which experience rapid mutation and become increasingly drug­resistant. A homology model of the H5N1­NA[8] from the highly pathogenic chicken H5N1 A viruses isolated during the 2003– 2004 influenza outbreaks in Japan was built based on the crystal structure of N9­NA complexed with DANA (PDB code: 1F8B). It was found that the traditional constituent